Bad dilution, circa 250M shares on issue post raise, assuming the 30c options will also be executed. $500M takeover required to match Sumi's $2 offer from 2019.
The good to come of this CR:
1. When this cash runs out, we will have clinical trial results from DFU, GvHD and Renal trials.
2. Maybe the gag on brokers by SI is over?
Bad dilution, circa 250M shares on issue post raise, assuming...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
-0.005(3.13%) |
Mkt cap ! $35.02M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.5¢ | 15.5¢ | $22.43K | 139.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 58708 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 9763 | 1 |
View Market Depth
| Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |